1. Home
  2. PAR vs STTK Comparison

PAR vs STTK Comparison

Compare PAR & STTK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo PAR Technology Corporation

PAR

PAR Technology Corporation

HOLD

Current Price

$14.54

Market Cap

640.6M

Sector

Miscellaneous

ML Signal

HOLD

Logo Shattuck Labs Inc.

STTK

Shattuck Labs Inc.

HOLD

Current Price

$6.16

Market Cap

538.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
PAR
STTK
Founded
1968
2016
Country
United States
United States
Employees
N/A
N/A
Industry
Office Equipment/Supplies/Services
Biotechnology: Pharmaceutical Preparations
Sector
Miscellaneous
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
640.6M
538.3M
IPO Year
1995
2020

Fundamental Metrics

Financial Performance
Metric
PAR
STTK
Price
$14.54
$6.16
Analyst Decision
Strong Buy
Buy
Analyst Count
5
7
Target Price
$33.20
$10.00
AVG Volume (30 Days)
1.2M
539.5K
Earning Date
05-07-2026
05-01-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
53.02
EPS
N/A
N/A
Revenue
$455,547,000.00
$1,000,000.00
Revenue This Year
$9.82
N/A
Revenue Next Year
$11.27
N/A
P/E Ratio
N/A
N/A
Revenue Growth
30.16
N/A
52 Week Low
$11.59
$0.71
52 Week High
$72.15
$8.33

Technical Indicators

Market Signals
Indicator
PAR
STTK
Relative Strength Index (RSI) 50.99 43.42
Support Level $13.85 $5.85
Resistance Level $15.10 $6.81
Average True Range (ATR) 0.98 0.46
MACD 0.04 -0.08
Stochastic Oscillator 49.88 27.07

Price Performance

Historical Comparison
PAR
STTK

About PAR PAR Technology Corporation

PAR Technology Corp is a foodservice technology company providing omnichannel cloud-based software and hardware solutions to the restaurant industry in three restaurant categories - quick service, fast casual, and table service - and the retail industry, including convenience and fuel retailers (C-Stores). Its product and service offerings include point-of-sale, customer engagement and loyalty, digital ordering and delivery, operational intelligence, payment processing, hardware, and related technologies, solutions, and services. The company generates revenue from subscription service, Sale of Hardware products, and Professional Service.

About STTK Shattuck Labs Inc.

Shattuck Labs Inc is a biotechnology company specializing in the development of potential treatments for inflammatory and immune-mediated diseases. It is developing a potentially first-in-class antibody for the treatment of inflammatory bowel disease (IBD) and other inflammatory and immune-mediated diseases. The company's expertise in protein engineering and the development of novel tumor necrosis factor (TNF) receptor therapeutics comes together in its main program, SL-325, which has the potential to be a first-in-class death receptor 3 (DR3) antagonist antibody. In addition, the company is developing SL-425, a half-life extended version of SL-325, and multiple other preclinical DR3-based bispecific antibodies, for the treatment of patients with IBD.

Share on Social Networks: